| Early Risk Prediction of Ovarian Cancer Using Multimodal Clinical and Biomarker Data |
Vanshika Sharma |
Chandigarh University |
PLCO |
Feb 23, 2026 |
PLCO-2020 |
| Validation of CA-125 Kinetic Models for Early Ovarian Cancer Detection Using Machine Learning |
Fahad Kiani |
CrisPRO.ai |
PLCO |
Feb 23, 2026 |
PLCO-2010 |
| Standardization of Imaging Interpretation for Early Lung Cancer Detection, Intelligent Learning Platforms, and Public Education Outreach |
Dr. Yeun-Chung Chang |
The Radiological Society of the Republic of China (RSROC) |
NLST |
Feb 20, 2026 |
NLST-1493 |
| Plasma proteomics markers for risk prediction of incident lung cancer |
Charles Swanton |
Francis Crick Institute |
PLCO |
Feb 19, 2026 |
2025-0069 |
| DNA methylation and dietary sodium intake |
Jeong Yun (John) Yang |
Columbia University Irving Medical Center |
PLCO |
Feb 17, 2026 |
PLCO-2023 |
| Dietary Advanced Glycation End-Products (dAGE) and Prostate Cancer |
Susan Steck |
University of South Carolina |
PLCO |
Feb 13, 2026 |
PLCO-2021 |
| Validation of a Morphology-Based Risk Taxonomy (Favorable, Borderline, Unfavorable Histology) for Prostate Cancer Using PLCO Trial Data |
Enrico Munari |
University Hospital Trust Verona |
PLCO |
Feb 4, 2026 |
PLCOI-2019 |
| Bone Marrow Extracellular Matrix Gene Expression Analysis for Cancer Prognosis and Bone Metastasis Prediction: An 82-Gene Panel Study Using PLCO Trial Data |
Shelly Peyton |
Trustees of Tufts College |
PLCO |
Feb 4, 2026 |
PLCO-2011 |
| Causal predictive modeling of survival of Breast cancer: A comparative study with machine learning, traditional survival modeling methods, and causal survival models |
Hansapani Rodrigo |
University of Texas Rio Grande Valley |
PLCO |
Feb 4, 2026 |
PLCO-2015 |
| Calibration of a microsimulation model of lung cancer natural history in Australia |
Marianne Weber |
The University of Sydney |
NLST |
Feb 4, 2026 |
NLST-1495 |
| Epstein-Barr virus-associated neo-antigens in advanced prostate cancer |
Denong Wang |
SRI International |
PLCO |
Feb 2, 2026 |
2025-0062 |
| Evaluating lung cancer screening by competing mortality |
Rebecca Landy |
American Cancer Society |
NLST |
Jan 29, 2026 |
NLST-1496 |
| Impact of a secondary biomarker on time-to-event risk prediction of prostate cancer mortality in a screening cohort |
Kristian Stensland |
The University of Michigan |
PLCO |
Jan 26, 2026 |
PLCO-2012 |
| Identifying histological features of lung cancer using deep learning |
Jennifer Beane |
Trustees of Boston University |
NLST |
Jan 26, 2026 |
NLST-1494 |
| Prevalence and Prognostic Significance of Dendriform Pulmonary Ossification in the National Lung Screening Trial |
Kyung Hee Lee |
University of Pittsburgh |
NLST |
Jan 26, 2026 |
NLST-1491 |
| Foundation models for precision non-small cell lung cancer treatment |
Mitchell Chen |
Imperial College London |
NLST |
Jan 26, 2026 |
NLST-1490 |
| Association between microplastic concentration in whole blood and risk of colorectal cancer in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial |
Rena Jones |
National Cancer Institute |
PLCO |
Jan 26, 2026 |
2025-0059 |
| Incidence Rates of Lung and Bladder Cancer According to Smoking Status and Tumor Subtype: An Analysis of Absolute Risk in Never Smokers |
Sarina Murray |
National Cancer Institute |
PLCO |
Jan 16, 2026 |
PLCO-2017 |
| Causal predictive modeling of survival of Breast cancer: A comparative study with machine learning, traditional survival modeling methods along and causal survival models |
Malinda Iluppangama |
Loyola University Maryland |
PLCO |
Jan 8, 2026 |
PLCO-2009 |
| Generalizing breast cancer screening to more representative populations |
Sarah Robertson |
Dartmouth College |
HIPB |
Jan 5, 2026 |
HIPB-18 |
